Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Xilio Therapeutics

Market Cap: US$39.3m

A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.

Caribou Biosciences

Market Cap: US$198.4m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

aTyr Pharma

Market Cap: US$93.2m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

CorMedix

Market Cap: US$877.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Merck KGaA

Market Cap: €46.2b

Operates as a science and technology company in Germany.

BLIS Technologies

Market Cap: NZ$21.7m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.

Hanmi Pharm

Market Cap: ₩4.8t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Celemics

Market Cap: ₩25.0b

Designs, manufactures, and distributes sequencing kits in South Korea.

Jiangsu Sihuan Bioengineering

Market Cap: CN¥2.3b

Engages in the pharmaceutical business in China.

Guanhao BiotechLtd

Market Cap: CN¥4.1b

Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥17.2b

Operates as contract development and manufacturing organization company in China and internationally.

CTCBIO

Market Cap: ₩166.9b

Provides various pharmaceutical products in South Korea and internationally.

Haisco Pharmaceutical Group

Market Cap: CN¥61.3b

Researches, develops, manufactures, and sells pharmaceutical products in China.

DongKook Pharmaceutical

Market Cap: ₩843.4b

Produces and sells pharmaceutical products in South Korea and internationally.

Oncocross

Market Cap: ₩120.3b

Develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.7b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.

Shaanxi Panlong Pharmaceutical Group Limited By Share

Market Cap: CN¥3.1b

Researches and develops, produces, and sells Chinese patent medicines in China.

3SBio

Market Cap: HK$73.5b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Sino Biopharmaceutical

Market Cap: HK$143.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

SCM Lifescience

Market Cap: ₩44.2b

Operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses.

TaiwanJ Pharmaceuticals

Market Cap: NT$642.6m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

High Tech Pharm

Market Cap: ₩141.0b

Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.

ImmuneOncia Therapeutics

Market Cap: ₩425.0b

An immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer.

Consun Pharmaceutical Group

Market Cap: HK$13.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Zhaoke Ophthalmology

Market Cap: HK$2.0b

An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.

Improve Medical Instruments

Market Cap: CN¥2.4b

Engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally.

Immutep

Market Cap: AU$374.3m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

G.F.C Green Fields Capital

Market Cap: ₪121.3m

Does not have significant operations.

JBM (Healthcare)

Market Cap: HK$2.4b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

China Traditional Chinese Medicine Holdings

Market Cap: HK$12.0b

China Traditional Chinese Medicine Holdings Co.

Binh Dinh Pharmaceutical and Medical Equipment

Market Cap: ₫5.1t

Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.

Central Pharmaceutical No3

Market Cap: ₫1.2t

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

OPC Pharmaceutical

Market Cap: ₫1.5t

Engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.

Mega Lifesciences

Market Cap: ฿27.2b

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.

Abbott India

Market Cap: ₹642.0b

Operates as a pharmaceutical company in India.